Saad F - Search Results

1

Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer.

Taplin ME, Antonarakis ES, Ferrante KJ, Horgan K, Blumenstein B, Saad F, Luo J, de Bono JS. Taplin ME, et al. Among authors: saad f. Eur Urol. 2019 Dec;76(6):843-851. doi: 10.1016/j.eururo.2019.08.034. Epub 2019 Sep 18. Eur Urol. 2019. PMID: 31542304 Clinical Trial.

2

Role of bisphosphonates in prostate cancer.

Saad F, Schulman CC. Saad F, et al. Eur Urol. 2004 Jan;45(1):26-34. doi: 10.1016/j.eururo.2003.10.003. Eur Urol. 2004. PMID: 14667511 Review.

3

Bone health in men with prostate cancer: diagnostic and therapeutic considerations.

Saad F, Perrotte P, Bénard F, McCormack M, Karakiewicz PI. Saad F, et al. Can J Urol. 2005 Jun;12 Suppl 2:9-15. Can J Urol. 2005. PMID: 16018826 Review.

4

Therapeutic approach to hormone-refractory prostate cancer.

Saad F, Al Dejmah A, Perrotte P, McCormack M, Bénard F, Valiquette L, Karakiewicz PI. Saad F, et al. Can J Urol. 2006 Apr;13 Suppl 2:52-6. Can J Urol. 2006. PMID: 16672130 Review.

5

Sunitinib relieves renal cell carcinoma spinal cord compression.

Trinh QD, Cardinal E, Gallina A, Perrotte P, Saad F, Karakiewicz PI. Trinh QD, et al. Among authors: saad f. Eur Urol. 2007 Jun;51(6):1741-3. doi: 10.1016/j.eururo.2006.10.050. Epub 2006 Nov 3. Eur Urol. 2007. PMID: 17126991

6

Predictors of skeletal complications in men with hormone-refractory metastatic prostate cancer.

Smith MR, Cook RJ, Coleman R, Brown J, Lipton A, Major P, Hei YJ, Saad F. Smith MR, et al. Among authors: saad f. Urology. 2007 Aug;70(2):315-9. doi: 10.1016/j.urology.2007.03.071. Urology. 2007. PMID: 17826496 Free PMC article. Clinical Trial.

7

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer.

Carducci MA, Saad F, Abrahamsson PA, Dearnaley DP, Schulman CC, North SA, Sleep DJ, Isaacson JD, Nelson JB; Atrasentan Phase III Study Group Institutions. Carducci MA, et al. Among authors: saad f. Cancer. 2007 Nov 1;110(9):1959-66. doi: 10.1002/cncr.22996. Cancer. 2007. PMID: 17886253 Free article. Clinical Trial.

8

Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

Jeldres C, Suardi N, Walz J, Saad F, Hutterer GC, Bhojani N, Shariat SF, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI. Jeldres C, et al. Among authors: saad f. Eur Urol. 2008 Jul;54(1):107-16. doi: 10.1016/j.eururo.2007.10.038. Epub 2007 Oct 30. Eur Urol. 2008. PMID: 17996358

9

High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

Jeldres C, Suardi N, Saad F, Montorsi F, Shariat SF, Perrotte P, Bhojani N, Walz J, Hutterer GC, Graefen M, Valiquette L, Karakiewicz PI. Jeldres C, et al. Among authors: saad f. Eur Urol. 2008 Jul;54(1):97-105. doi: 10.1016/j.eururo.2007.10.070. Epub 2007 Nov 6. Eur Urol. 2008. PMID: 17997022

10

Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.

Capitanio U, Perrotte P, Zini L, Suardi N, Antebi E, Cloutier V, Jeldres C, Shariat SF, Duclos A, Arjane P, Saad F, Montorsi F, Karakiewicz PI. Capitanio U, et al. Among authors: saad f. Urology. 2009 Jun;73(6):1323-7. doi: 10.1016/j.urology.2008.10.026. Epub 2009 Apr 18. Urology. 2009. PMID: 19376563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,415 results

Search Page

Filters